BioLife Solutions, a developer, manufacturer and marketer of proprietary hypothermic storage and cryopreservation freeze media, has added three key opinion leaders in the biobanking, drug discovery and regenerative medicine markets to its Scientific Advisory Board (SAB).
John McMannis, Ph.D., executive vice president of manufacturing at Mesoblast, and previously was director of the cellular therapy laboratory at the department of stem cell transplantation, division of cancer medicine, at the University of Texas MD Anderson Cancer Center in Houston, Texas.
Jon Rowley, Ph.D., innovation director of cell processing technologies at Lonza Biosciences.
